- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07460024
Implementation of Timely Management of Sepsis and Septic Shock Protocol in the Emergency Department and Intensive Care Unit: A Quality Improvement Project at AFHJ
Study Title: Implementation of a Sepsis Management Protocol at Armed Forces Hospital Jazan (AFHJ).
Purpose: The purpose of this quality improvement project is to determine if implementing a standardized, evidence-based "sepsis bundle" can improve the care and survival of patients with sepsis and septic shock in the Emergency Department (ED) and Intensive Care Unit (ICU).
What the Study Involves:
Researchers will implement a specific set of clinical guidelines based on the international Surviving Sepsis Campaign. This include:
Using a scoring system (NEWS2 and SOFA) to identify sick patients earlier.
Ensuring patients receive five critical treatments (the "one-hour bundle") within 60 minutes of diagnosis, including blood tests, IV fluids, and antibiotics.
Comparison:
The study will compare the outcomes of 74 patients treated before the protocol was introduced (the "Pre-protocol group") to 46 patients treated after the new protocol was put into effect (the "Protocol group").
Expected Outcome:
The goal is to increase the number of patients who receive all necessary treatments within one hour from less than 15% to at least 60%. The study also aims to see if this protocol leads to shorter hospital stays and lower mortality rates.
Study Overview
Status
Intervention / Treatment
Detailed Description
Project Overview Sepsis and septic shock represent a significant global health burden, characterized by life-threatening organ dysfunction resulting from a dysregulated host response to infection. Clinical outcomes are heavily dependent on the speed of recognition and the initiation of evidence-based interventions. This quality improvement (QI) project was designed to address gaps in the timely management of sepsis at the Armed Forces Hospital Jazan (AFHJ) by implementing a standardized clinical protocol in the Emergency Department (ED) and Intensive Care Unit (ICU).
Protocol Framework
The intervention is based on an adaptation of the international Surviving Sepsis Campaign (SSC) guidelines. The protocol integrates two validated scoring systems to enhance diagnostic accuracy and urgency:
National Early Warning Score 2 (NEWS2): Utilized for the initial screening of patients to identify physiological deterioration early.
Sequential Organ Failure Assessment (SOFA): Used to formally assess and track the degree of organ dysfunction.
The One-Hour Bundle Intervention
The core of the clinical intervention is the "One-Hour Bundle," which mandates that five key actions be initiated within 60 minutes of sepsis recognition:
Lactate Measurement: To identify tissue hypoperfusion (repeated if initial lactate is >2 mmol/L).
Microbiological Diagnostics: Obtaining blood cultures prior to the administration of antimicrobial agents to ensure targeted therapy later.
Empiric Antimicrobials: Rapid administration of broad-spectrum antibiotics to combat the underlying infection.
Fluid Resuscitation: Immediate infusion of 30 mL/kg of crystalloid for patients presenting with hypotension or high lactate levels.
Vasopressor Support: Application of vasopressors (typically norepinephrine) if the patient remains hypotensive during or after fluid resuscitation to maintain a Mean Arterial Pressure (MAP) of ≥65 mm Hg.
Implementation Strategy
The project utilized a multi-disciplinary approach involving consultants from Anesthesiology, ICU, and Surgery, alongside nursing leadership and medication safety officers. Implementation was supported by:
Educational Workshops: Training frontline staff on NEWS2 and SOFA scoring.
Visual Aids: Strategic placement of the sepsis algorithm in high-acuity areas.
Quality Oversight: Continuous monitoring of compliance through data collection sheets to identify and remove systemic barriers to rapid care.
Study Methodology The project followed a quasi-experimental pre-post intervention design. The Pre-protocol phase involved a retrospective review of cases to establish a baseline of care compliance and patient outcomes. The Protocol phase involved the prospective enrollment of patients following the formal introduction of the new guidelines. By standardizing the "time to antibiotics" and "time to fluid bolus," the study aimed to demonstrate that protocolized care directly correlates with reduced Intensive Care Unit (ICU) and hospital Length of Stay (LOS), as well as a significant reduction in sepsis-related mortality rates.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients aged 18 years or older.
- Clinical suspicion of sepsis or a confirmed diagnosis of sepsis upon admission to the Emergency Department (ED) or Intensive Care Unit (ICU).
- Presence of symptoms meeting the criteria for the sepsis management protocol during the study period.
Exclusion Criteria:
- Patients transferred from other healthcare facilities after sepsis treatment had already been initiated.
- End-of-life cases or patients with "Do Not Attempt Resuscitation" (DNAR) status where data sets are incomplete.
- Cases with insufficient medical documentation that prevents accurate outcome measurement or bundle compliance tracking.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Pre-protocol Group (Baseline)
his retrospective cohort includes 74 adult patients with suspected sepsis or septic shock treated at AFHJ between January and December 2024.
This arm represents the "standard of care" prior to the formal implementation of the adapted sepsis management protocol.
|
Traditional sepsis management as practiced at the institution prior to the implementation of the standardized QI protocol.
This care was characterized by inconsistent bundle compliance and variable timing of antibiotic administration and fluid resuscitation.
|
|
Experimental: Protocol Group (Intervention)
his prospective cohort includes 46 adult patients with suspected sepsis or septic shock treated at AFHJ between January and July 2025.
These patients were managed according to a structured sepsis protocol involving early screening (NEWS2/SOFA) and the "one-hour bundle."
|
A multi-component clinical management strategy focusing on early recognition and rapid treatment. Key elements include: Screening: Use of National Early Warning Score 2 (NEWS2) at triage. Diagnosis: Use of Sequential Organ Failure Assessment (SOFA) to identify organ dysfunction. The One-Hour Bundle: Execution of five tasks within 60 minutes: (1) Measuring lactate, (2) Obtaining blood cultures, (3) Administering broad-spectrum antibiotics, (4) IV fluid resuscitation (30 mL/kg) for hypotension or high lactate, and (5) Vasopressors to maintain MAP ≥ 65 mmHg. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance rate with the full 5-item Sepsis One-Hour Bundle.
Time Frame: Within 1 hour of sepsis recognition (Time Zero).
|
The percentage of patients who received all five components of the adapted Surviving Sepsis Campaign (SSC) bundle within 60 minutes of "Time Zero" (triage or recognition).
The five components are: 1. Lactate measurement, 2. Blood cultures, 3. Broad-spectrum antibiotics, 4. 30 mL/kg crystalloid fluid, and 5. Vasopressors (if indicated).
|
Within 1 hour of sepsis recognition (Time Zero).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of Stay (LOS) in the Intensive Care Unit (ICU).
Time Frame: From ICU admission to ICU discharge (average 5-7 days).
|
The duration of stay in the ICU measured in days.
This measure evaluates if the timely implementation of the sepsis bundle leads to faster clinical stabilization and earlier discharge from critical care.
|
From ICU admission to ICU discharge (average 5-7 days).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Disease Attributes
- Infections
- Inflammation
- Shock
- Pathological Conditions, Signs and Symptoms
- Critical Illness
- Sepsis
- Shock, Septic
- Systemic Inflammatory Response Syndrome
- Health Care Quality, Access, and Evaluation
- Therapeutics
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Epidemiologic Study Characteristics
- Clinical Protocols
Other Study ID Numbers
- REC-47/08/1796
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
Clinical Trials on Standard Clinical Care
-
Azienda Ospedaliera Città della Salute e della...University of Turin, ItalyCompleted
-
Rigshospitalet, DenmarkOdense University HospitalNot yet recruiting
-
University of UtahBaylor College of Medicine; National Institute of Nursing Research (NINR); University... and other collaboratorsCompletedParkinson's DiseaseUnited States
-
Denver Health and Hospital AuthorityAmerican Diabetes AssociationCompletedType 1 Diabetes | Type 2 DiabetesUnited States
-
Fundación Pública Andaluza Progreso y SaludTelefónica S.A.; Agency of Social Services and Dependency of Andalusia; Salud...UnknownChronic Lung Disease | Chronic Heart DiseaseSpain
-
Federal University of MaranhaoUniversidade Federal de AlfenasNot yet recruitingSystemic Lupus Erythematosus | Lupus Nephritis | Drug Monitoring | Mycophenolic AcidBrazil
-
University of MiamiUniversity of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH) and other collaboratorsCompletedObstructive Sleep Apnea | Down SyndromeUnited States
-
Hasselt UniversityUniversity Hospital, Antwerp; Universiteit Antwerpen; University of RegensburgRecruiting
-
University of MalagaKing's College LondonWithdrawnMild Cognitive ImpairmentSpain
-
University of FloridaBrooks Rehabilitation; Foundation for Physical Therapy ResearchCompletedLow Back Pain | Neck PainUnited States